HQY (NASDAQ) Rule 144 notice lists vesting lots; 1,744 shares sold on 01/09/2026

Rhea-AI Filing Summary

HealthEquity, Inc. (HQY) filed a Rule 144 notice reporting planned sales of Common Stock by an affiliate and recorded recent sales. The filing lists specific restricted stock vesting lots and a recent disposition of 1,744 shares on 01/09/2026 for $166,091.76.

Insights

Securities Compliance Analyst

Rule 144 notice lists vesting lots and a recent sale of HQY common stock.

The form records restricted stock vesting entries and identifies a reported sale of 1,744 shares on 01/09/2026 with proceeds of $166,091.76. The filing appears procedural to notify the market under resale rules.

Timing and volumes of future sales depend on vesting and Rule 144 eligibility; subsequent filings will show additional activity if and when sales occur.

Key Figures

Reported recent sale: 1,744 shares Proceeds from recent sale: $166,091.76 Vesting lot example: 1,586 shares +3 more

6 metrics

Reported recent sale 1,744 shares Securities Sold During The Past 3 Months, <date>01/09/2026</date>

Proceeds from recent sale $166,091.76 Securities Sold During The Past 3 Months, <date>01/09/2026</date>

Vesting lot example 1,586 shares Restricted Stock Vesting, <date>03/27/2024</date>

Vesting lot example 1,792 shares Restricted Stock Vesting, <date>04/02/2025</date>

Securities line item 3,378 Listed near issuer security block (raw entry from file)

Monetary figure shown $283,198.90 Listed near issuer security block (raw entry from file)

Key Terms

Restricted Stock Vesting, Rule 144, Securities Sold During The Past 3 Months, Issuer

4 terms

Restricted Stock Vesting financial

"Restricted Stock Vesting | ISSUER | 1586 | 04/06/2026"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Rule 144 regulatory

"Form 144 notice reporting planned sales under resale rules"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Securities Sold During The Past 3 Months regulatory

"Securities Sold During The Past 3 Months | Common Stock | 01/09/2026"

Issuer financial

"Restricted Stock Vesting | ISSUER |"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney 2000 Westchester Ave Purchase NY 10577-2530	3378	283198.90	84478406	04/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/27/2024	Restricted Stock Vesting	ISSUER			1586	04/06/2026	Compensation
Common Stock	04/02/2025	Restricted Stock Vesting	ISSUER			1792	04/06/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Fiore C/O HealthEquity, Inc. 15 W.Scenic Pointe Dr. Ste, 100 Draper UT 84020	Common Stock	01/09/2026	1744	166091.76

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the HQY Form 144 report?

It reports planned and recent sales of HealthEquity common stock under resale rules. The filing lists vesting lots and shows a sale of 1,744 shares on 01/09/2026 for $166,091.76, notifying the market per Rule 144.

Who is selling HQY shares under this filing?

The filing references an affiliate/issuer-related holder and a named seller (Michael Fiore) for recent activity. It lists restricted stock vesting events and the selling party for the past sale on 01/09/2026.

How many HQY shares were sold recently according to the filing?

The document shows a reported sale of 1,744 shares on 01/09/2026 for $166,091.76. This sale is shown in the "Securities Sold During The Past 3 Months" section.

Do these Rule 144 notices change HQY's outstanding share count?

No. The Form 144 notifies of resale activity; it does not by itself change shares outstanding. Outstanding share totals are not altered by this notice and any change would appear in separate company filings.